Cargando…
T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity
As a breakthrough immunotherapy, T cell bispecific antibodies (T-BsAbs) are a promising antibody therapy for various kinds of cancer. In general, T-BsAbs have dual-binding specificity to a tumor-associated antigen and a CD3 subunit forming a complex with the TCR. This enables T-BsAbs to crosslink tu...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619951/ https://www.ncbi.nlm.nih.gov/pubmed/34832954 http://dx.doi.org/10.3390/ph14111172 |